What is Cardarine (GW501516) 25mg (50 Tablets)
Cardarine (GW501516) is a small-molecule PPARδ agonist investigated for its effects on lipid handling, oxidative metabolism, and endurance-related pathways in controlled laboratory models.
Potential Research Effects
• PPARδ pathway activation and fatty-acid oxidation programs
• Endurance capacity and oxidative muscle-fiber phenotype exploration
• Lipid handling, triglyceride transport, and metabolic flexibility
• Glucose homeostasis and insulin-sensitivity modeling
• Body-composition and energy-expenditure research
Includes 50 research-use tablets per unit.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes. These materials are supplied for in-vitro research only (“in glass”) and are not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency. They are not intended to diagnose, treat, cure, or prevent any disease.
Any form of bodily introduction, clinical testing, or therapeutic application is strictly prohibited.
